Article(electronic)January 1998
Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study
In: Journal of the Society for Gynecologic Investigation: official publication of the Society for Gynecologic Investigation, Volume 5, Issue 1, p. 47A-47A
Checking availability at your location
This article is also available at your library: |
electronic
print
Languages
English
Publisher
Springer Science and Business Media LLC
ISSN: 1556-7117
DOI
Report Issue